Augmented reality (AR) goggles have enabled a girl who lost her sight through a brain tumour to ‘see’ the animals she loves again.After being registered blind at age 16, Maisy McAdam dearly wished she
On public display for the first time in Australasia at O=Mega19, the new multi-purpose, fully automated Revo FC from Optopol combines the latest optical coherence tomography (OCT) functionality with a
The American Academy of Ophthalmology has recommended sunglasses be worn outdoors to prevent keratitis and other damage, even when the sun isn’t shining, after a European study reported over half of ocular exposure comes from scattering and cloud reflection.
Dominating Zeiss’ stand and drawing the eye as soon as you entered O=Mega19’s exhibition hall, was the futuristic and somewhat robot-looking Visufit 1000, the company’s new digital 3D centration
A new emoji is being proposed to change the image of glasses wearers from geek to chic.A social media vote on four options provided a winning image – a smiling face with modern black frames – to be
A phase I clinical trial in Italy has shown recombinant human nerve growth factor (rhNGF) to be a potential treatment for dry eye disease (DED).A total of 40 patients with moderate to severe,
Icelandic start-up Risk Medical Solutions has launched an app to encourage diabetics worldwide to better self-monitor their risks of sight loss.The Retina Risk app, developed by University of Iceland
Taking pride of place on Designs for Vision’s busy stand was Icare Home, a home tonometer for glaucoma suspects and post-surgical monitoring, which has now been combined with new Icare mHome software,
WELKS findings released
The following is a response from the Southern Cross Health Society to an edited version of an article first penned by Ophthalmology New Zealand (ONZ) about its concerns regarding funding for
An urgent overhaul of the New Zealand health system to remedy current inequalities of care is being called for in a University of Auckland-led critique published in The Lancet.Professor Felicity
Research shows a novel eye drop can be used for sustained delivery of antifibrotic drugs in patients with fibrosis associated with bacterial keratitis, according to a study published in Nature’s
